Natural Killer Cells and Anti-Cancer Therapies: Reciprocal Effects on Immune Function and Therapeutic ResponseElisa C. Toffoli, Tanja D. de Gruijl, Abdolkarim Sheikhi et al.|Cancers|2021Cited by 41
Enhancement of NK Cell Antitumor Effector Functions Using a Bispecific Single Domain Antibody Targeting CD16 and the Epidermal Growth Factor ReceptorElisa C. Toffoli, Roeland Lameris, Lisa A. King et al.|Cancers|2021Cited by 22
Allogeneic NK cells induce monocyte-to-dendritic cell conversion, control tumor growth, and trigger a pro-inflammatory shift in patient-derived cultures of primary and metastatic colorectal cancerElisa C. Toffoli, Tanja D. de Gruijl, Amanda van Vliet et al.|Journal for ImmunoTherapy of Cancer|2023Cited by 21
Allogeneic NK cells induce the <i>in vitro</i> activation of monocyte-derived and conventional type-2 dendritic cells and trigger an inflammatory response under cancer-associated conditionsElisa C. Toffoli, Tanja D. de Gruijl, A.A. van Vliet et al.|Clinical & Experimental Immunology|2024Cited by 6
634 Production and testing of a novel bispecific nanobody construct targeting NK cells and EGFR expressing malignanciesElisa C. Toffoli, Abdolkarim Sheikhi, Roeland Lameris et al.|Regular and Young Investigator Award Abstracts|2020Cited by 1